Still, GOBP analyses showed an involvement of classical cancer-key genes (SMAD4, STAT3, RUNX1, TP53,...), and again epigenetic factors (JARID1A, KDM5B), E2Fs, and MYC, as in the previous normal-tumor comparison. The gene discussed is SMAD4; the disease is cancer.